Subsequently, further studies have demonstrated that GACAT3 acts as an oncogenic lncRNA and contributes to the development of various cancers, including breast cancer [11], colorectal cancer [14], bladder cancer [15], and glioma [16]. This evidence concerns the gene GACAT3 and breast carcinoma.